Dep1 in arteriolvenous cell fate - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Dep1 in arteriolvenous cell fate

Description:

'The receptor protein-tyrosine phosphatase, Dep1, acts in arterial/venous cell ... Beuchle D, Schach U, Fabian C, N sslein-Volhard C. The identification of genes ... – PowerPoint PPT presentation

Number of Views:47
Avg rating:3.0/5.0
Slides: 36
Provided by: quln
Category:

less

Transcript and Presenter's Notes

Title: Dep1 in arteriolvenous cell fate


1
Dep1 in arteriol/venous cell fate
  • Carla H, Kelsey H, Lucas H

2
introduction.
  • The receptor protein-tyrosine phosphatase, Dep1,
    acts in arterial/venous cell fate decisions in
    zebrafish development
  • Fiona Rodriguez, Andrei Vacaru, John Overvoorde,
    Jeroen den Hertog.
  • 2008.

3
PTPs vs. PTKs.
  • tyrosine residue (de)phosphorylation
  • PTK protein tyrosine kinase
  • PTP protein tyrosine phosphatase
  • large families
  • typically "paired"
  • less known about PTPs

4
PTPs, subfamilies.
  • 2 main classes ? 17 subfamilies
  • RPTPs "receptor" PTPs
  • R3 RPTPs four members
  • single PTP domain
  • Dep1 in this subfamily

5
Dep1.
  • "density-enhanced PTP1"
  • vascular endothelial cells of arterial, capillary
    vessels of some organs
  • Dep1 cancer
  • Dep1 overexpression ? tumor suppression in
    cultures
  • mouse Ptprj gene cand. for colon cancer
    susceptibility
  • often, PTPRJ gene deleted in human cancer cases

6
Dep1 mice.
  • gene-targeting of Dep1 ? death before 11.5 days
  • in-frame replacement of cytoplasmic sequences
  • vascularization failure, disorganized vasc.
    structures
  • homozygous mutants ? death (similar timing)
  • "subtle effects" e.g. larger vessels
  • implicates Dep1, but w/o molecular mech.
  • genetic ablation of Ptprj ? viable fertile
  • immunoblotting confirms absence of Dep1

7
Dep1 C. elegans
  • Dep1 ? binary cell fate decisions
  • negative regulation of EGFR signaling
  • amplifies small changes in EGFR
  • complex feedback mechanism
  • full activation EGFR/RAS/MAPK in 1o vulval cells
  • inactivation in 2o vulval cells

8
Dep1 zebrafish.
  • Dep1a
  • 12 fibronectin-like repeats 4 gt mammalian
    Dep1
  • Dep1b
  • not fully sequenced yet

9
Dep1.
10
Dep1 zebrafish.
  • morpholino injections
  • Dep1a, Dep1b essential for normal blood
    circulation
  • Dep1 knockdown ?
  • reduced arterial markers
  • expanded venous markers
  • rescue experiments
  • Phosphatidylinositol-3-Kinase
  • Grl/hey2
  • Notch

11
Zebrafish.
  • why Zebrafish?
  • 12 wk life cycle
  • hatch 2 days after fertilization
  • transparent embryo
  • A/V axis

12
Zebrafish.
  • VIDEO.

13
(No Transcript)
14
(No Transcript)
15
establishing dep1 expression.
R3 family RPTP interspecies DEP1 homology gt
intraspecies R3 PTP homology
16
zebrafish Dep1s, human PTPRJ
comparison of flanking genes.
17
whole mount expression of dep1a during early
zebrafish development
whole mount expression of dep1b during early
zebrafish development
18
sections of 30 hpf and 48 hpf embryos
DA dorsal aorta NC notochord NT neural
tube PCV posterior cardinal vein
19
O-dianisidine staining of hemoglobin of wild-type
(A) and Dep1a-MO1
20
does Dep1a knockdown affect vasculogenesis?
No, overall vasculature appears normal.
21
functionality of vessels?
WT fluorescence detected through the entire
aorta Dep1a-MO1Rhodamine dextran
staining Only found in aortic bifurcation Dep1a-
MO2 rhodamine dextran Did not reach posterior
22
tbx20.
  • tbx20 a dorsal aorta marker

23
tbx20.
class 1 (normal) wild type expression in dorsal
aorta class 2 (mild) patchy expression in some
cells class 3 (severe) expression completely
absent
24
Observed defects were specific
rescue!
25
Dep1a, Dep1b synergy.
  • cdh5 marker for vascular endothelial cells
  • not affected
  • myoD somite marker
  • somitogenesis not affected by Dep1 knockdown

26
arterial fate.
27
Position of dorsal aorta indicated by the arrow.
28
venous fate.
29
(No Transcript)
30
signaling pathway.
31
discussion.
  • comparisons with mice experiments
  • Zebrafish knockdown ?? Mouse GFP replacement
  • Dep1 mutants had reduced arterial differentiation
  • accd by ectopia of venous markers
  • Dep1a/Dep1b-MOs vs. grl-MOs ?
  • Dep1a/Dep1b mutants phenocopies of grl knockdown
  • coinjection of these MOs was additive
  • Dep1-MOs abolished grl expression in aorta
  • upstream activation?

32
discussion.
  • VEGF also involved in sim. processes
  • Dep1 ? VEGFR2?
  • they do interact in tissue culture in vitro?
  • parallels between Dep1 function amongst homologs
  • Zebrafish arteriol/venous cell fate
  • C. elegans vulval cell fate
  • Mouse vascular cell fate
  • TAKE-HOME MESSAGE
  • Dep1 definite role in cell fate determination

33
critique.
  • Dep1s role in cancer?
  • mentioned, not explored
  • not fully explaining reasons for results in some
    cases
  • e.g. knockdown did not cause the same phenotype
    mechanism?
  • overall well done
  • experiments results - thorough, clear, logical
  • intro discussion glossed over some issues
  • some topics in discussion data not provided?

34
future experiments.
  • role of Dep1 in cancer?
  • overexpression ? tumor suppression
  • many cases, deletion ? cancer
  • poor vascular development ? tumor?
  • exact mechanism of action?
  • confirmation of the hypothesized signaling
    pathway
  • possibly acts on VEGFR2/RAF/MEK/ERK pathway?
  • whats with the mouse thing!?

35
references.
  • Haffter P, Granato M, Brand M, Mullins MC,
    Hammerschmidt M, Kane DA, Odenthal J, van Eeden
    FJ, Jiang YJ, Heisenberg CP, Kelsh RN,
    Furutani-Seiki M, Vogelsang E, Beuchle D, Schach
    U, Fabian C, Nüsslein-Volhard C. The
    identification of genes with unique and essential
    functions in the development of the zebrafish,
    Danio rerio. Development 123 1-36.
  • Rodriguez F, Vacaru A, Overvoorde J, den Hertog
    J. 2008. The receptor protein-tyrosine
    phosphatase, Dep1, acts in arterial/venous cell
    fate decisions in zebrafish development.
    Developmental Biology 324, 122130.
  • Takahashi T, Takahashi K, St John PL, Fleming PA,
    Tomemori T, Watanabe T, Abrahamson DR, Drake CJ,
    Shirasawa T, Daniel TO. 2003. A mutant receptor
    tyrosine phosphatase, CD148, causes defects in
    vascular development. Mol Cell Biol. 23,
    18171831.
  • Trapasso F, Drusco A, Costinean S, Alder H,
    Aqeilan RI, Iuliano R, Gaudio E, Raso C, Zanesi
    N, Croce CM, Fusco A. 2006. Genetic ablation of
    Ptprj, a mouse cancer susceptibility gene,
    results in normal growth and development and does
    not predispose to spontaneous tumorigenesis. DNA
    Cell Biol. 25, 376382.
  • all images presented under Fair Use.
Write a Comment
User Comments (0)
About PowerShow.com